当前位置:首页 - 行情中心 - 联盛化学(301212) - 财务分析 - 利润表

联盛化学

(301212)

  

流通市值:5.72亿  总市值:22.87亿
流通股本:2700.00万   总股本:1.08亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入516,164,255.38400,438,176.67233,350,600.291,041,133,695.75
营业收入516,164,255.38400,438,176.67233,350,600.291,041,133,695.75
二、营业总成本444,801,201.61334,755,745.21194,039,600.39821,780,696.86
营业成本410,195,707.36311,505,163.68177,652,353.65788,855,249.29
税金及附加2,443,297.662,247,429.771,131,233.334,514,683.07
销售费用7,581,226.395,094,624.462,767,229.7110,888,230.25
管理费用23,378,131.6114,476,939.876,965,992.2330,093,634.04
研发费用21,569,337.815,853,119.037,999,391.1632,940,383.29
财务费用-20,366,499.21-14,421,531.6-2,476,599.69-45,511,483.08
其中:利息费用188,194.69117,875.6754,749.991,940,946.41
其中:利息收入16,321,628.589,980,923.085,198,647.7915,873,247.19
加:公允价值变动收益-77,377.94-1,001,756.3128,026.911,132,076.03
加:投资收益-624,679.3298,317.71-139,649.83-2,678,277.38
资产处置收益---37,926.41
资产减值损失(新)-74,043.06-74,043.06--2,386,190.76
信用减值损失(新)4,190,210.18955,513.29-1,526,557.8-44,633.58
其他收益5,649,542.191,829,360.91670,270.735,746,659.54
营业利润平衡项目0000
四、营业利润80,426,705.8267,489,824.0138,443,089.91221,160,559.15
加:营业外收入817,543.74749,046.38222,008.722,822.78
减:营业外支出665,505.87295,807.52-2,419,579.67
利润总额平衡项目0000
五、利润总额80,578,743.6967,943,062.8738,665,098.63218,743,802.26
减:所得税费用12,022,162.459,193,710.734,859,315.627,579,765.79
六、净利润68,556,581.2458,749,352.1433,805,783.03191,164,036.47
持续经营净利润68,556,581.2458,749,352.1433,805,783.03191,164,036.47
归属于母公司股东的净利润67,259,425.7858,777,008.7133,794,308.43182,965,402.93
少数股东损益1,297,155.46-27,656.5711,474.68,198,633.54
(一)基本每股收益0.620.540.311.85
(二)稀释每股收益0.620.540.311.85
九、综合收益总额68,556,581.2458,749,352.1433,805,783.03191,164,036.47
归属于母公司股东的综合收益总额67,259,425.7858,777,008.7133,794,308.43182,965,402.93
归属于少数股东的综合收益总额1,297,155.46-27,656.5711,474.68,198,633.54
公告日期2023-10-282023-08-292023-04-282023-04-19
审计意见(境内)标准无保留意见
TOP↑